"Our continuing research shows that more frequent home hemodialysis is a clinically differentiated therapy," said
On-Site Hemodialysis in Skilled Nursing Facilities:
"With an aging population, the number of nursing home residents needing dialysis is expected to grow," said Dr. Weinhandl. "Using the NxStage System One to provide more frequent and
Solo Home Hemodialysis:
Another abstract illustrated findings from the NxStage patient preference survey that supported
More Frequent Home Hemodialysis:
NxStage researchers also presented new data that were collected with its remote patient management system, Nx2me Connected Health®, and showed that patients on more frequent home hemodialysis had lower risk of intradialytic hypotension than patients on conventional in-center hemodialysis.
"Data consistently show that more frequent home hemodialysis has cardiovascular benefits," said Dr. Weinhandl. "The therapy may be especially useful in settings with historically poor clinical and economic outcomes, such as nursing homes."
Full abstracts can be read online at http://annualdialysisconference.org/abstracts/.
Visit www.NxStage.com for more information about therapy options with the NxStage System One.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.
A trained and qualified patient may dialyze alone, without a care partner present (solo home hemodialysis), provided the patient and physician agree that solo home hemodialysis is appropriate. Certain risks associated with hemodialysis treatment are increased when performing solo home hemodialysis because no one is present to help the patient respond to health emergencies. If patients experience needles coming out, blood loss, or very low blood pressure during solo home hemodialysis, they may lose consciousness or become physically unable to correct the health emergency. Losing consciousness or otherwise becoming impaired during any health emergency while alone could result in significant injury or death. Additional ancillary devices and training are required when performing solo home hemodialysis. Patients should consult with their physician to understand the risks and responsibilities associated with home and/or more frequent hemodialysis, and solo home hemodialysis using the NxStage System One. Additionally, the reported benefits of home and/or more frequent hemodialysis may not be experienced by all patients. Patients and providers are encouraged to contact their state regulators to discuss state-specific regulations that may impact dialysis in the skilled nursing facility setting.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared specifically by the
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the
1Cornelis T, Kotanko P, Goffin E, van der Sande FM, Kooman JP, Chan CT.
Intensive hemodialysis in the (nursing) home: the bright side of geriatric ESRD
2Yang A, Lee WY, Hocking K. Survival comparison of daily home hemodialysis vs.
conventional in the nursing home setting. Nephrol News Issues. 2015
View original content with multimedia:http://www.prnewswire.com/news-releases/seven-unique-nxstage-abstracts-presented-during-the-38th-annual-dialysis-conference-300612593.html
Kristen K. Sheppard, Esq., +1-978-332-5923